The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience.
about
Novel strategies in glioblastoma surgery aim at safe, supra-maximum resection in conjunction with local therapiesCharacterization of Dynamic Behaviour of MCF7 and MCF10A Cells in Ultrasonic Field Using Modal and Harmonic AnalysesThe future of high-grade glioma: Where we are and where are we going.Rapid regression of glioblastoma following carmustine wafer implantation: A case reportOpening the ventricle during surgery diminishes survival among patients with newly diagnosed glioblastoma treated with carmustine wafers: a multi-center retrospective study.Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.Chronic Phase Intracranial Hemorrhage Caused by Ruptured Pseudoaneurysm Induced by Carmustine Wafer Implantation for Insulo-opercular Anaplastic Astrocytoma: A Case Report.Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma.Intraoperative pathological diagnosis in 205 glioma patients in the pre-BCNU wafer era: retrospective analysis with intraoperative implantation of BCNU wafers in mind.Delayed post-operative haemorrhage after carmustine wafer implantation: a case series from two UK centres.Brain Tumor Diagnostics and Therapeutics with Superparamagnetic Ferrite Nanoparticles.Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.The Survival Advantage of "Supratotal" Resection of Glioblastoma Using Selective Cortical Mapping and the Subpial Technique.High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
P2860
Q27023618-AF38E65D-8177-4C22-880B-E76ECF9AF906Q30405262-20C28D74-B19C-4B6B-880C-F43C646BB4DCQ35114090-B38F04F8-B935-49D9-83E1-E58826E1AEDBQ37001342-0C14DA96-CA37-4530-8698-E0256AC2DA1EQ38769659-C13BC810-40AE-4EC2-B2E1-BC62F4797BEAQ39046974-075293A1-A845-47DE-861D-68D31826A24DQ43151074-8CF7C32D-DBE6-4AE5-AC42-062EEDEC8768Q45983482-A63815E3-6E4D-4E18-BE65-114A0E37110AQ46379710-7D057CB6-A467-49B7-B5F2-0D9EDA9FDDABQ46514870-8BBC7B79-D5F1-4E0A-8215-1EFE161EC7F6Q47699015-880BDC16-0B71-41D5-8C59-68CE1DF44692Q47968808-33B553BD-DA1A-4E64-9B96-A4D8B1F1F124Q50756545-AD3D93C8-C48A-417A-B26E-A77E2F5F46E3Q55460949-6275EC66-9575-4743-B6FE-4F235D679443
P2860
The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The combination of carmustine ...... onale and clinical experience.
@en
type
label
The combination of carmustine ...... onale and clinical experience.
@en
prefLabel
The combination of carmustine ...... onale and clinical experience.
@en
P2093
P2860
P1476
The combination of carmustine ...... onale and clinical experience.
@en
P2093
A Gutenberg
C B Lumenta
H M Mehdorn
M Westphal
W E K Braunsdorf
P2860
P2888
P304
P356
10.1007/S11060-013-1110-X
P577
2013-03-28T00:00:00Z
P6179
1028203266